Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study of THR-184 in Patients at Risk of Developing Cardiac Surgery Associated-Acute Kidney Injury (CSA-AKI)

ClinicalTrials.gov ID: NCT01830920

Public ClinicalTrials.gov record NCT01830920. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 1:18 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center, Parallel-Group, Randomized, Double Blind, Adaptive Study Investigating the Safety and Efficacy of THR-184 in Patients at Increased Risk of Developing Cardiac Surgery Associated-Acute Kidney Injury (CSA-AKI)

Study identification

NCT ID
NCT01830920
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Thrasos Innovation, Inc.
Industry
Enrollment
452 participants

Conditions and interventions

Interventions

  • THR-184 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2013
Primary completion
Aug 31, 2015
Completion
Aug 31, 2015
Last update posted
Apr 19, 2017

2013 – 2015

United States locations

U.S. sites
31
U.S. states
18
U.S. cities
29
Facility City State ZIP Site status
University of Alabama-Birmingham Birmingham Alabama 35294
University of Southern California Los Angeles California 90033
Stanford University Stanford California 94305
Harbor - University of California Los Angeles Medical Center Torrance California 90503
Danbury Hospital Danbury Connecticut 06810
River City Clinical Research Jacksonville Florida 32207
University of Chicago Chicago Illinois 60637
Advocate Christ Medical Center Oak Lawn Illinois 60453
Indiana Ohio Heart Fort Wayne Indiana 46804
Indiana Heart-St. Vincent Medical Group Indianapolis Indiana 46290
Maine Medical Center Portland Maine 04102
John Hopkins University Baltimore Maryland 21287
Suburban Hospital Bethesda Maryland 20814
Massachusetts General Hospital Boston Massachusetts 02114
Baystate Medical Center Springfield Massachusetts 01199
Cardiac and Vascular Research Center of Northern Michigan Petoskey Michigan 49770
Covenant Medical Center Saginaw Michigan 48602
Washington University St Louis Missouri 63110
St. Joseph's Regional Medical Center Paterson New Jersey 07503
St. Peter's Hospital Albany New York 12208
Columbia University New York New York 10032
Duke University Medical Center Durham North Carolina 27710
Durham VA Medical Center Durham North Carolina 27710
Lindner Research Center-Christ Hospital Cincinnati Ohio 45219
The Ohio State University Medical Center Columbus Ohio 43210
Erlanger Health System Chattanooga Tennessee 37404
Memorial Hospital Chattanooga Tennessee 37404
Vanderbilt University Medical Center Nashville Tennessee 37212
Baylor University Medical Center, Soltero Cardiovascular Research Center Dallas Texas 75226
University of Texas, Houston Houston Texas 77030
Cardiothoracic Surgical Associates Richmond Virginia 23225

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01830920, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 19, 2017 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01830920 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →